Regeneron’s experimental therapy combo effective in untreated cancer patients

by admin | Dec 23, 2025 | News & Opinions

By Sriparna Roy – Reuters News – Regeneron (REGN.O), opens new tab said on Saturday its experimental cancer combination therapy was effective and showed disappearance of the disease in previously untreated patients with a type of blood cancer in the first...

The quest to slow aging leads scientists into the powerhouse of cells

by admin | Dec 22, 2025 | News & Opinions

by Mark Johnson – MSN – Aging taps us on the shoulder in many ways: wrinkles, thinning hair, loss of flexibility, slowing of the brain. But the process also unfolds at a more fundamental, microscopic level, as the energy source inside most cells...

Disarming cancer stem cells’ shield makes immunotherapy more effective

by admin | Dec 19, 2025 | News & Opinions

by UChicagoMedicine – Immunotherapy has revolutionized cancer care by training the immune system to detect and destroy tumors. For many patients, it works very well in shrinking tumors and sending cancer into remission, an undetectable state of cancer. But that...

Vycellix Prepares for First-in-Human Study of Novel Allogeneic Cell Therapy Powered by Its Universal Cell Engineering Platform

by admin | Dec 18, 2025 | News & Opinions

By Vycellix – – Single-step CD45-engager technology shows robust immune evasion with functional persistence in pre-clinical models – Phase 1 study to evaluate ‘off-the-shelf’ natural killer cell cancer immunotherapy in the treatment of multiple...

Crispr gene-editing technology offers new hope for HIV cure but faces delivery challenges

by admin | Dec 17, 2025 | News & Opinions

By Tosin Thompson – Chemistry World – Two years ago, the UK became the first country to approve Casgevy, a Crispr-based therapy for the blood disorders sickle cell disease and β-thalassaemia. This year saw the world’s first personalised Crispr therapy for...